loading page

Analysis of the clinical characteristics of 28 children with NF1 mutation-positive acute leukemia and literature review
  • +10
  • Pengli Huang,
  • Heng Dong,
  • Ruidong Zhang,
  • Peijing Qi,
  • Yuanyuan Zhang,
  • Jiaole Yu,
  • Jia Fan,
  • Yaguang Peng,
  • Jie Yang,
  • Wenting Lu,
  • Bei Hou,
  • Huiqing Liu,
  • Huyong Zheng
Pengli Huang
Capital Medical University
Author Profile
Heng Dong
Capital Medical University
Author Profile
Ruidong Zhang
Capital Medical University
Author Profile
Peijing Qi
Capital Medical University
Author Profile
Yuanyuan Zhang
Capital Medical University
Author Profile
Jiaole Yu
Capital Medical University
Author Profile
Jia Fan
Capital Medical University
Author Profile
Yaguang Peng
Beijing Children's Hospital Capital Medical University
Author Profile
Jie Yang
Capital Medical University
Author Profile
Wenting Lu
Capital Medical University
Author Profile
Bei Hou
Capital Medical University
Author Profile
Huiqing Liu
Capital Medical University
Author Profile
Huyong Zheng
Capital Medical University

Corresponding Author:[email protected]

Author Profile

Abstract

Objective: To summarize the clinical characteristics, treatment effects and survival outcomes of children with NF1 mutation-positive acute leukemia. Methods: The clinical data and prognosis of 28 patients with NF1 mutation-positive acute leukemia treated at Beijing Children’s Hospital, Capital Medical University, between January 2017 and February 2024 were retrospectively analyzed. Results: A total of 28 patients were included in the study, with a median follow-up of 16 (1.2–85.5) months. Twelve patients had acute lymphoblastic leukemia, of whom 75.0% were at intermediate risk. Complete response (CR) was achieved in the bone marrow after induction chemotherapy, with a minimal residual disease (MRD) of 1×10 -3 at Day 33. Fifteen patients had acute myeloid leukemia (AML), of whom 66.7% were at high risk. The CR rate in the bone marrow was 86.6% at Day 28. Eleven (73.3%) patients survived at the end of follow-up. One patient with acute promyelocytic leukemia had standard risk and a good response. The overall survival rate of children with NF1 mutations was comparable to that of children with no mutations. However, children with germline NF1 mutations had a poor prognosis compared with those with somatic mutations, especially in AML patients. The frequency of NF1 mutations was 2–87.7%. The clinical manifestations of 3 patients with neurofibromatosis included café-au-lait macules, freckles, xanthogranuloma, scoliosis, and benign intracranial lesions. Conclusion: Most NF1 mutations in children with acute leukemia are somatic mutations that do not affect overall survival. Children with leukemia complicated with neurofibromatosis should undergo lifelong follow-up.